These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3489926)

  • 21. Second episodes of Haemophilus influenzae type b disease following rifampin prophylaxis of the index patients.
    Cates KL; Krause PJ; Murphy TV; Stutman HR; Granoff DM
    Pediatr Infect Dis J; 1987 Jun; 6(6):512-5. PubMed ID: 3497378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifampin for eradicating carriage of multiply resistant Haemophilus influenzae b.
    Campos J; Garcia-Tornel S; Roca J; Iriondo M
    Pediatr Infect Dis J; 1987 Aug; 6(8):719-21. PubMed ID: 3499591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rifampin prophylaxis v placebo for household contacts of children with Hemophilus influenzae type b disease.
    Murphy TV; Chrane DF; McCracken GH; Nelson JD
    Am J Dis Child; 1983 Jul; 137(7):627-32. PubMed ID: 6602542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemophilus influenzae type b in a nursery school: the value of biotyping.
    Prober CG; Ipp MM; Bannatyne RM
    Pediatrics; 1982 Feb; 69(2):215-8. PubMed ID: 6977129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemophilus influenzae type b disease in a day-care center. Report of an outbreak.
    Ward JI; Gorman G; Phillips C; Fraser DW
    J Pediatr; 1978 May; 92(5):713-7. PubMed ID: 347042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak.
    Granoff DM; McKinney T; Boies EG; Steele NP; Oldfather J; Pandey JP; Suarez BK
    Pediatrics; 1986 Mar; 77(3):289-95. PubMed ID: 3485275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An epidemiological study of Haemophilus influenzae at a Brazilian day care center.
    da Silva ME; Marin JM
    Braz J Infect Dis; 2001 Oct; 5(5):260-8. PubMed ID: 11779452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of rifampin chemoprophylaxis for contacts of patients infected with Haemophilus influenzae type B.
    Green M; Li KI; Wald ER; Guerra N; Byers C
    Antimicrob Agents Chemother; 1992 Mar; 36(3):545-7. PubMed ID: 1622163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Need for prevention of invasive Haemophilus influenzae type b infections in Geneva, Switzerland.
    Gervaix A; Suter S
    Vaccine; 1993; 11 Suppl 1():S34-7. PubMed ID: 8447172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts.
    Glode MP; Daum RS; Boies EG; Ballard TL; Murray M; Granoff DM
    Pediatrics; 1985 Oct; 76(4):537-42. PubMed ID: 3900905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. World-wide strategies for immunization against invasive Haemophilus influenzae type b disease.
    Iwarson S
    Vaccine; 1993; 11 Suppl 1():S28-9. PubMed ID: 8447169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meningitis and epiglottitis: a new immunisation against haemophilus influenzae type b infections.
    Lungmuss J
    Health Visit; 1989 Jun; 62(6):179-80. PubMed ID: 2786515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the distribution of Haemophilus influenzae type b clones associated with widespread infant vaccination in Finland.
    van Alphen L; Takala AK; Geelen-van den Broek L; Dankert J; Eskola J
    J Infect Dis; 1992 Dec; 166(6):1340-5. PubMed ID: 1431251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b.
    Barbour ML; Mayon-White RT; Coles C; Crook DW; Moxon ER
    J Infect Dis; 1995 Jan; 171(1):93-8. PubMed ID: 7798687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention.
    Fleming DW; Leibenhaut MH; Albanes D; Cochi SL; Hightower AW; Makintubee S; Helgerson SD; Broome CV
    JAMA; 1985 Jul; 254(4):509-14. PubMed ID: 3874293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.
    Takala AK; Eskola J; Leinonen M; Käyhty H; Nissinen A; Pekkanen E; Mäkelä PH
    J Infect Dis; 1991 Nov; 164(5):982-6. PubMed ID: 1940479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of vaccines and antibiotic prophylaxis in contacts and cases of Haemophilus influenzae type b (Hib) disease.
    Cartwright KA; Begg NT; Rudd PT
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R16-7. PubMed ID: 7511459
    [No Abstract]   [Full Text] [Related]  

  • 38. Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine.
    de Almeida AE; de Filippis I; Abreu AO; Ferreira DG; Gemal AL; Marzochi KB
    Braz J Med Biol Res; 2005 May; 38(5):777-81. PubMed ID: 15917960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Haemophilus influenzae meningitis in a child with complete immunisation].
    Zjevíková A; Roznovský L; Krízová P; Lebedová V
    Klin Mikrobiol Infekc Lek; 2004 Feb; 10(1):22-4. PubMed ID: 15100979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina.
    Martin M; Casellas JM; Madhi SA; Urquhart TJ; Delport SD; Ferrero F; Chamany S; Dayan GH; Rose CE; Levine OS; Klugman KP; Feikin DR
    Pediatr Infect Dis J; 2004 Sep; 23(9):842-7. PubMed ID: 15361724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.